Screening of inhibitors for anchorage-independent tumor cell growth from microbial metabolites and their application in cancer chemotherapy
Screening of inhibitors for anchorage-independent tumor cell growth from microbial metabolites and their application in cancer chemotherapy
批准号:
14560083
负责人:
IGARASHI Yasuhiro
金额:
$0.64万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Inhibitors for anchorage-independent growth of tumor cells were screened from microbial secondary metabolites. Five hundred strains of actinomycetes and one hundred strains of fungi were cultured in liquid medium and the 1-butanol extracts were subjected to the screening. One actinomycete and one fungus showed potent inhibitory activity against the anchorage-independent growth of human colon tumor DLD-1 cells. The active compounds were isolated from the culture broth by chromatography using HPLC analysis and bioassay.From the actinomycete, a novel antitumor compound TT2149-C was isolated. The producing-strain, was identified as Streptomyces thermoviolaceus TP-A0648 by taxonomic studies. TT2149-C is an analog of spicamycin, which was isolated from Streptomyces sp. as an antitumor antibiotic. TT2149-C inhibited the anchorage-independent growth of DLD-1 cells with the IC_<50> of 29 nM whereas it inhibited the anchorage-dependent growth with. the IC_<50> of 68 nM. TT2149-C showed very pote … More nt cytocidal activity against a variety of human cancer cell lines with the IC50 of 0.1 to 120 nM.A novel antitumor compound anicequol was isolated from the fungus Penicillium aurantiogriseum TP-F0213. The structure of anicequol was confirmed as (3β, 5α, 7β, 11β, 16β-16-acetoxy-3,7,11-trihydroxyergost-22-en-6-one by X-ray diffraction of bis-p-bromobenzoate of anicequol. Anicequol inhibited the anchorage-independent growth of DLD-1 cells with the IC_<50> of 1.2 μM whereas it inhibited the anchorage-dependent growth with the IC_<50> of 40 μM. The selectivity of anicequol is superior to that of TT2149-C. Anicequol did not show activity against protein kinases, farnesyl transferase and tublin function. Structure-activity relationship (SAR) of anicequol, was studied using synthetic derivatives. Acetylation of 3-and 7-hydroxy groups resulted in the loss of activity. However, the acetylation of 3-hydroxy group reduced the toxicity to the anchorage-dependent growth but enhanced the cytotoxicity to the anchorage-independent growth. SAR of anicequol will be studied furthermore. Less
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Y.Igarashi: "Anicequol, a novel inhibitor for anchorage-independent growth of tumour cells from Penicillium aurantiogriseum Dierckx TP-F0213"Journal of Antibiotics. Vol.55. 371-376 (2002)
Y.Igarashi:“Anicequol,一种来自橙青霉 Dierckx TP-F0213 的肿瘤细胞非贴壁依赖性生长的新型抑制剂”《抗生素杂志》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Y.Igarashi et al.: "Anicequol, a novel inhibitor for anchorage-independent growth of tumour cells from Penicillium aurantiogriseum Dierckx TP-F0213"Journal of Antibiotics. Vol.55. 371-376 (2002)
Y.Igarashi 等人:“Anicequol,一种新型抑制剂,用于来自金黄色青霉 Dierckx TP-F0213 的肿瘤细胞的锚定非依赖性生长”《抗生素杂志》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Development of new antifungal and anti-HIV agents based on the mannose binding quinone glycoside
-
批准号:16580090
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.54万
-
财政年份:2004
-
负责人:IGARASHI Yasuhiro
-
依托单位:
海外基金